RecruitingNCT06802861

Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia


Sponsor

University of Tennessee Graduate School of Medicine

Enrollment

50 participants

Start Date

Jan 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study is examining how the body processes aspirin in pregnant women who are at risk of preeclampsia (dangerously high blood pressure during pregnancy), and whether differences in aspirin metabolism are linked to metabolic problems like insulin resistance. **You may be eligible if...** - You are pregnant and less than 16 weeks along - Your doctor has recommended low-dose aspirin to reduce your risk of preeclampsia - You are willing to take aspirin as directed and complete study assessments - You can speak and read English **You may NOT be eligible if...** - You have Type 1 or Type 2 diabetes, or gestational diabetes - You have a platelet disorder or bleeding condition (such as ITP or TTP) - You have an allergy to aspirin or NSAIDs - You have a multiple pregnancy (twins or more) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Tennessee Medical Center

Knoxville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06802861


Related Trials